Stockreport

NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today ann [Read more]